Laos Government Plans to Classify E-cigarettes as Addictive Substances

Regulations by 2FIRSTS.ai
Nov.30.2023
Laos Government Plans to Classify E-cigarettes as Addictive Substances
Laos plans to include e-cigarettes in its list of addictive substances due to the increasing prevalence among youth.

According to a report by Xinhua News Agency on November 30th, the Laotian government plans to amend and supplement certain provisions of the drug prevention and control law, including the inclusion of e-cigarettes in the list classified as addictive substances and precursors.

 

During the sixth regular session of the ninth Lao National Assembly, Deputy Prime Minister and Minister of Public Security Vilay Lakhamfong emphasized that e-cigarettes, which are one of the emerging issues of social concern, have not yet been included in Laos' list of prohibited items.

 

Therefore, e-cigarettes will soon be added to the list of products that include banned addictive substances and precursors.

 

According to a report from the Ministry of Health of Laos in October, tobacco-related diseases were the leading cause of death in the country in 2019, accounting for approximately 65% of all deaths. It is estimated that tobacco annually causes hundreds of thousands of chronic illnesses and results in the deaths of 6,700 people.

 

The use of tobacco among young people in Laos, particularly e-cigarettes, is steadily growing and becoming increasingly prevalent. As a result, the Ministry of Health expresses concern that without timely measures to restrict it, the country will soon face a new wave of e-cigarette addiction, which is equally harmful as traditional tobacco.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
Argentine province of Santa Fe passes bill expanding smoking regulations to include e-cigarettes and heated tobacco products
The Santa Fe Provincial Chamber of Deputies has passed a bill amending the 2005 Provincial Anti-Smoking Law (No. 12,432) to include e-cigarettes, vaping devices, and heated tobacco products. Lawmaker Sonia Martorano, who authored the initiative, said the reform aims to strengthen prevention policies amid growing youth use, stressing that “even without nicotine, these devices are toxic.”
Nov.05 by 2FIRSTS.ai
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Group said its controlling shareholder, Jinjia Venture, will have part of its holdings auctioned by the Shenzhen Nanshan Court, involving 43.4 million shares. Earlier, the Shenzhen Intermediate Court announced another auction of 37.27 million shares. Together they represent 5.56% of total equity. Jinjia said the auctions will not affect company control.
Oct.23 by 2FIRSTS.ai
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
IHit-HyperV Ceramic Atomization Technology Achieves Commercial Maturity, Redefining the New Standard for Visible E-liquid Pod Systems
At the 2025 CHAMPS Trade Show, iHit Tech (SMISS Group) announced the commercial maturity of its IHit-HyperV ceramic atomization technology. The breakthrough boosts efficiency and flavor performance, setting a new benchmark for visible e-liquid pod systems.
Sep.15
Singapore's four-day joint operation to investigate e-cigarettes resulted in the arrest of four e-cigarette users
Singapore's four-day joint operation to investigate e-cigarettes resulted in the arrest of four e-cigarette users
Singapore's HSA & NEA held a 4-day joint op against e-cig use in Tampines, CBD & other areas: 4 offenders (24-43) caught, fined on-site; 27 e-cigs/accessories seized. Singapore also tightened e-cig enforcement, authorizing over 5k frontline officers on Sept 9; stricter penalties took effect Sept 1—1st under-18s: S$500 (≈US$389), 18+: S$700 (≈US$545); 2nd offenders: 3-mth rehab; 3rd+: prosecution, up to S$2k (≈US$1,557). Etomidate e-cig users face harsher penalties (higher fines, rehab) & prosecu
Sep.22 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
InterTabac 2025 Insights|PMI Showcases Full Portfolio: IQOS, VEEV, and ZYN in Dedicated Zones
InterTabac 2025 Insights|PMI Showcases Full Portfolio: IQOS, VEEV, and ZYN in Dedicated Zones
At InterTabac 2025 in Dortmund, 2Firsts observed that Philip Morris International (PMI) exhibited with a full product lineup and organized three key brands—IQOS (heated tobacco), VEEV (e-vapor), and ZYN (nicotine pouches)—into separate display areas.
Sep.19 by 2FIRSTS.ai